Search

Joslin Diabetes Center researchers take the first steps towards an autologous cell therapy for obesity.

What's new in business?

The industry must overcome enormous challenges in order to take the next steps in induced pluripotent stem cell technology.

How can we reduce animal testing in quality control procedures?

Cell therapy logistics is challenged by complex processes, inefficiency, and lack of flexibility to accommodate manufacturing, clinic, and patient needs

How to drive antibody drug development and manufacture forward safely and quickly.

When it comes to using AI in drug development, companies need to consider how they create and protect their intellectual property.

Kiran Mazumdar-Shaw shares the experiences that have helped shape her career, and the lessons learned along the way.

How is the Indian pharmaceutical industry adapting to meet new demands?

Virus-based vaccines were the first foray into immunization, but the field has had to move on and embrace new approaches.